Pharos, a San Francisco-based startup focused on hospital quality reporting, has successfully completed a $5 million seed round, highlighted by active interest from leading investors. The round was led by Felicis and saw contributions from General Catalyst, Moxxie, and Y Combinator.
The influx of capital is set to propel Pharos' efforts in advancing their automated platform for clinical quality reporting, which aims to relieve hospital staff of the burdensome task of manual data entry.
Founded by experienced clinicians and AI researchers in 2024, Pharos focuses on streamlining the submission process to state and national quality registries through its innovative automation technologies. The startup's platform not only simplifies data abstraction but also allows hospitals to analyze and understand the causes of patient safety issues such as sepsis mortality and pressure ulcers in a timely fashion.
According to CEO and co-founder Felix Brann, the current manual processes are time-consuming and draw clinical staff away from critical patient care duties, resulting in delays in data access. Pharos' automation solutions allow healthcare providers to gain real-time insights into their operational inefficiencies. It enables faster and more effective responses to potential patient safety threats.
Brann, along with CTO and co-founder Matthew Jones, brings a wealth of experience in deploying AI tools in healthcare environments, having previously implemented AI technologies in over 70 hospitals. This background is reinforced by the research credentials of Head of Research, Dr. Alex Clarke, who holds an MD and a PhD in Artificial Intelligence.
The support from Felicis and other investors is expected to sustain Pharos as it addresses these challenges, enhancing the transparency and efficiency of quality reporting in hospitals worldwide.
